Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
SL3-3 is a highly T-lymphomagenic murine retrovirus. The major genetic determinant of disease is the transcriptional enhancer, which consists of a repeated region with densely packed binding sites for several transcription factors, including AML1 (also known as core binding factor and polyoma enhanc...
שמור ב:
| הוצא לאור ב: | J Virol |
|---|---|
| Principais autores: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1997
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192069/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9311802/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.71.10.7273-7280.1997 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|